Novo Nordisk reports positive data from type 2 diabetes medicine trial
Novo Nordisk has announced positive headline results from Phase IIIb SUSTAIN FORTE trial of once-weekly...
Novo Nordisk has announced positive headline results from Phase IIIb SUSTAIN FORTE trial of once-weekly...
Novo Nordisk is set to resume the Phase III explorer 6, 7 and 8 clinical...
Biopharmaceutical firm Orphazyme has reported positive interim results from an open-label extension study of a...
Bavarian Nordic has reported data from the Phase III efficacy study of MVA-BN (Jynneos) vaccine,...
Bavarian Nordic has reported results from the first stage of a Phase II clinical trial...
Bavarian Nordic has started a Phase I clinical trial to assess its vaccine candidate MVA-BN...
Denmark-based biotechnology company Zealand Pharma has reported positive outcome for its dasiglucagon in the paediatric...
Novo Nordisk has reported positive results from the Phase IIIa PIONEER clinical trial programme of...
MC2 Therapeutics has completed enrollment for its Phase III study of MC2-01 PAD Cream to...
Gilead Sciences has entered a clinical collaboration with Denmark-based Novo Nordisk to evaluate a combination...